Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers

Brain

Volumn 125, Issue 8, 2002, Pages 1760-1771

  Greco, C M ^a   Hagerman, R J ^b   Tassone, F ^a   Chudley, A E ^d   Del Bigio, M R ^d   Jacquemont, S ^b   Leehey, M ^c   Hagerman, P J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Dementia; Huntington's; Mental retardation; Parkinsonism; Trinucleotide repeat

Indexed keywords

AGED; ALLELE; ARTICLE; CASE REPORT; CELL NUCLEUS INCLUSION BODY; CEREBELLAR ATAXIA; FRAGILE X SYNDROME; GENE SILENCING; HETEROZYGOTE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOCHEMISTRY; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; PROMOTER REGION; PURKINJE CELL; TRANSCRIPTION REGULATION; TREMOR; TRINUCLEOTIDE REPEAT;

EID: 0036345801     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf184     Document Type: Article

References (57)

1. Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study-preliminary data
2. Ubiquitin, cellular inclusions and their role in neurodegeneration
3. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test
4. The role of the ubiquitinproteasomal pathway in Parkinson's disease and other neurodegenerative disorders
5. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation
6. Behavioral and psychiatric disorders in adult male carriers of fragile X
7. Cell death in polyglutamine diseases
8. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1
9. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
10. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range
11. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X
12. Executive function and motor skill learning
13. Real time quantitative PCR
14. Analysis of neocortex in three males with the fragile X syndrome
15. Spinocerebellar ataxia type 7 (SCA7): A neurodegenerative disorder with neuronal intranuclear inclusions
16. Dendritic spine structural anomalies in fragile-X mental retardation syndrome
17. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination
18. Reply to Altschuler
19. Eosinophilic intranuclear inclusions in the hippocampal pyramidal neurons of a patient with amyotrophic lateral sclerosis
20. Transmission of the fra(X) haplotype from three nonpenetrant brothers to their affected grandsons
21. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9
22. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
23. Transmitting males and carrier females in fragile X-revisited
24. Neuronal intranuclear inclusion disease: Neuropathologic study of a case
25. Transmission of the FRAXA haplotype from three nonpenetrant brothers to their affected grandsons: An update with AGG interspersion analysis
26. Decreased cerebellar posterior vermis size in fragile X syndrome: Correlation with neurocognitive performance
27. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome
28. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain
29. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
30. Absence of expression of the FMR-1 gene in fragile X syndrome
31. Neuroanatomy of fragile X syndrome: The posterior fossa
32. Neuroanatomy in fragile X females: The posterior fossa
33. Neuroanatomy of fragile X syndrome: The temporal lobe
34. Neurodevelopmental effects of the FMR1 full mutation in humans
35. Postmortem examination of two fragile X brothers with an FMR1 full mutation
36. Phenotypic involvement in females with the FMR1 gene mutation
37. The neuropathology of CAG repeat diseases: Review and update of genetic and molecular features
38. Huntington's disease and dentatorubral-pallidoluysian atrophy: Proteins, pathogenesis and pathology
39. Prevalence of carriers of premutation-size alleles of the FMRI gene-and implications for the population genetics of the fragile X syndrome
40. Surprisingly low prevalance of FMR1 premutations among males from the general population
41. Adult fragile X syndrome. Clinico-neuropathologic findings
42. Pathological and neuropathological findings in two males with fragile-X syndrome
43. Adult fragile X syndrome: Neuropsychology, brain anatomy, and metabolism
44. Prediction of mental status in carriers of the fragile X mutation using CGG repeat length
45. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population
46. Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions
47. FMRP expression as a potential prognostic indicator in fragile X syndrome
48. Transcription of the FMR1 gene in individuals with fragile X syndrome
49. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome
50. Clinical involvement and protein expression in individuals with the FMR1 premutation
51. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
52. Rapid antibody test for fragile X syndrome
53. Rapid antibody test for diagnosing fragile X syndrome: A validation of the technique
54. Pathology of CAG repeat diseases
55. Fragile X genotype characterized by an unstable region of DNA
56. The morphology of Marinesco bodies (paranucleolar corpuscles) in the melanin-pigmented nuclei of the brain-stem